E.C.M. RES.:
ROLE OF IMAGINGINTEGRATONELLA GESTIONEDELLA PATOLOGIAONCOLOGICADEL CAVO ORALE

06 February 2026
Fondazione CNAO - PAVIA

TYPOLOGY

RES

QUESTIONS

- € 120,00 SOCI SIRM
- € 150,00 Medical Specialists in Otorinolaringoiatria, Oncology and Surgery Maxillofacial
- € 80,00 SIRM members enrolled in the study section of Odontostomatological Radiology and Capo-Collo
- € 250,00 NOT SOCI SIRM
- € 50,00 Doctors Assistants in Education Spec. in Radiodiagnostica(up to a maximum of 40)

DATE

06/02/2026

END DATE

06/02/2026
Sign in to join the course

Scientific rationale

The oncological pathology of the oral cable involves the region of the mouth, including the lips, the tongue, the palate, the retromolar trigon, the gums, the cheeks and the floor of the mouth. The most frequent isotype is represented by squamo-cellular carcinoma and early diagnosis is the prerogative of clinical evaluation and can have a significant impact on the quality of life and prognosis of the patient. The role of imaging diagnostics integrates the objective examination, in particular in assessing the extent of disease in deep planes with particular reference to the involvement of critical structures for the correct staging of disease and the choice of the most appropriate treatment.
The diagnostics of oral cavity tumors therefore requires a multidisciplinary approach that involves, in addition to the radiologist, other specialist figures (otolaryngologist surgeon, radiotherapist, oncologist, nuclear doctor, anatomical-pathologist). The event will be divided into a theoretical part, placing the Radiologist at the center of a confrontation with other specialists (otolaryngologist surgeon, radiotherapist, oncologist, nuclear doctor) emphasizing the importance of the multidisciplinary approach in managing this pathology and in a practical part with the interactive discussion of emblematic clinical cases, presented by young radiologists. Particular attention will be paid to the correct use of the different imaging techniques and their referral to provide adequate information on the stage of disease, favoring the correct management of the therapeutic process.

CONTRIBUTION

 

 

START
06 February 2026
END OF COURSE
06 February 2026
TYPOLOGY
RES
LOCATION
Fondazione CNAO - PAVIA
PARTICIPANTS
100
TARGETS
SURRGES

REFERENCE SPIPLINES:
RADIODIAGNOSTICA - RADIOTERAPIA - MEDICINA NUCLEARE – ONCOLOGIA - OTORINOLARINGOIATRIA - CHIRURGIA MAXILLO FACCIALE
ECM ID
16 – 469271
N. CREDITS RES
7
E-MAIL
info@studio-congressi.com
Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00